Clinical Trials
All Clinical Trials - Page 32 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT04189848Phase 4Completed
Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
Semaglutide
- NCT04186494N/ACompleted
Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea
Liraglutide
- NCT03986008Phase 3Unknown
Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients
Liraglutide
- NCT02198209Phase 4Withdrawn
Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
Liraglutide
- NCT04137328N/AUnknown
Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide
Liraglutide
- NCT04196231Phase 4Completed
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
Liraglutide
- NCT04166773Phase 2Completed
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Tirzepatide
- NCT04166058Phase 3Completed
Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
Linaclotide
- NCT04061200Phase 4Unknown
Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria
Semaglutide
- NCT04733508N/AUnknown
Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes
Exenatide
- NCT04027023Phase 4Unknown
Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT03796884Phase 2Active Not Recruiting
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
Linaclotide
- NCT04143945Phase 2Completed
A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
Semaglutide
- NCT03928379Phase 1Completed
A Study of LY3305677 in Participants With Type 2 Diabetes
Mazdutide
- NCT04159766Phase 2Completed
A Study With NLY01 in Subjects With Type 2 Diabetes
Exenatide
- NCT04110145Phase 2Completed
Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation
Linaclotide
- NCT04125836Phase 3Completed
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Octreotide
- NCT04102189Phase 3Completed
A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity
Semaglutide
- NCT04179734Phase 4Completed
Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder
PT-141
- NCT04103034Phase 1Completed
A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers
Desmopressin
- NCT04109508Phase 1Completed
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets
Semaglutide
- NCT04109547Phase 3Completed
A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes
Semaglutide
- NCT04060992Phase 4Unknown
Hormonal Effects of the Oral Gonadotropin Releasing Hormone (GnRH) Antagonist at Different Periods of the Menstrual Cycle
Gonadorelin
- NCT04113005EARLY_Phase 1Unknown
Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer
Desmopressin
- NCT04026113Phase 3Completed
Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)
Linaclotide
- NCT04098562Phase 2Unknown
Efficacy of LL-37 Cream on Bacteria Colonization, Inflammation Response and Healing Rate of Diabetic Foot Ulcers
Ll-37
- NCT04200625N/ACompleted
Semaglutide vs Dulaglutide on Epicardial Adipose Tissue
Semaglutide
- NCT05340192Phase 1Completed
Effect of Octreotide on Saliva
Octreotide
- NCT04168892N/ACompleted
Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response
Gonadorelin
- NCT04083820N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)
Semaglutide
- NCT03877939N/ACompleted
Detection of Kisspeptins and miRNAs in Patients With Non-viable Pregnancy
Kisspeptin
- NCT04050670Phase 1Completed
A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes
Tirzepatide
- NCT04074161Phase 3Completed
Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity
Semaglutide
- NCT04076059Phase 3Active Not Recruiting
An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Gonadorelin
- NCT04026256Phase 4Completed
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
Teriparatide
- NCT04532801Phase 1Withdrawn
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance
Kisspeptin
- NCT05162183N/ACompleted
Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
Liraglutide
- NCT03648554Phase 4Unknown
Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
Dulaglutide
- NCT04039503Phase 3Completed
A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
Tirzepatide
- NCT04074317Phase 2Completed
Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D
Pramlintide
- NCT04004988Phase 1Completed
A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants
Tirzepatide
- NCT04076462Phase 3Completed
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Octreotide
- NCT03997539Phase 2Unknown
A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Gonadorelin
- NCT03841058Phase 2Active Not Recruiting
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Abaloparatide
- NCT04032197Phase 1Completed
A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes
Semaglutide
- NCT04067999N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
Semaglutide
- NCT04064411Phase 3Completed
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
Abaloparatide
- NCT04126603Phase 4Completed
Impact of Semaglutide on CD34+ EPC and Fat Derived MSC
Semaglutide
- NCT03770728Phase 3Terminated
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea
Efpeglenatide
- NCT03895463N/AWithdrawn
Study to Assess the Use of Lanreotide Autogel® 120 mg in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) in Routine Clinical Practice
Lanreotide